Evotec awarded funding for neuroprotection programme
This article was originally published in Scrip
Executive Summary
Evotec of Germany has been awarded a €2.5 million research grant from the BMBF (German Federal Ministry of Education and Research) to fund R&D activities into serine racemase for potential use in the development of therapeutics for multiple sclerosis and other neurodegenerative diseases.